UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$440M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 3 |
CRH
CRH
|
+$275M |
| 4 |
Advanced Micro Devices
AMD
|
+$228M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$538M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$473M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$397M |
| 4 |
Microsoft
MSFT
|
+$366M |
| 5 |
UnitedHealth
UNH
|
+$312M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.42% |
| 2 | Financials | 6.7% |
| 3 | Healthcare | 6.28% |
| 4 | Consumer Discretionary | 5.01% |
| 5 | Industrials | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
Washington Trust Bancorp
WASH
$750M
| $574K | ﹤0.01% |
21,813
+6,647
| +44% | +$190K |
|
4552
Maravai LifeSciences
MRVI
$861M
| $573K | ﹤0.01% |
57,276
-84,192
| -60% | -$924K |
|
|
RDFN
4553
DELISTED
Redfin
RDFN
| $572K | ﹤0.01% |
81,269
+21,783
| +37% | +$239K |
|
4554
Omnicell
OMCL
$1.69B
| $572K | ﹤0.01% |
12,699
-30,131
| -70% | -$1.83M |
|
4555
4D Molecular Therapeutics
FDMT
$621M
| $572K | ﹤0.01% |
44,897
-8,953
| -17% | -$150K |
|
|
MRC
4556
DELISTED
MRC Global
MRC
| $571K | ﹤0.01% |
55,728
-7,351
| -12% | -$73.9K |
|
4557
Republic Bancorp
RBCAA
$1.91B
| $571K | ﹤0.01% |
12,955
+43
| +0.3% | +$1.92K |
|
|
RAPT
4558
DELISTED
RAPT Therapeutics
RAPT
| $570K | ﹤0.01% |
4,288
-1,637
| -28% | -$267K |
|
|
NTG
4559
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
| $570K | ﹤0.01% |
16,689
-1,721
| -9% | -$60.6K |
|
4560
Materion
MTRN
$5.9B
| $570K | ﹤0.01% |
5,592
-6,954
| -55% | -$759K |
|
4561
Paysafe
PSFE
$352M
| $570K | ﹤0.01% |
47,502
+11,797
| +33% | +$144K |
|
4562
Unisys
UIS
$210M
| $569K | ﹤0.01% |
164,911
+24,754
| +18% | +$105K |
|
4563
Pebblebrook Hotel Trust
PEB
$2.04B
| $568K | ﹤0.01% |
41,821
-74,722
| -64% | -$1.07M |
|
|
PMF
4564
DELISTED
PIMCO Municipal Income Fund
PMF
| $567K | ﹤0.01% |
67,509
-10,588
| -14% | -$101K |
|
4565
Central Garden & Pet Co Class A
CENTA
$2.43B
| $567K | ﹤0.01% |
17,680
-17,483
| -50% | -$557K |
|
|
ERC
4566
Allspring Multi-Sector Income Fund
ERC
$261M
| $567K | ﹤0.01% |
62,309
-11,510
| -16% | -$109K |
|
4567
PUT
Crocs
CROX
$6.26B
| $565K | ﹤0.01% |
+6,400
| New | +$658K |
|
|
TIXT
4568
CALL
DELISTED
TELUS International
TIXT
| $564K | ﹤0.01% |
+74,000
| New | +$706K |
|
4569
Archer Aviation
ACHR
$5.37B
| $564K | ﹤0.01% |
111,410
+47,551
| +74% | +$273K |
|
4570
Phibro Animal Health
PAHC
$1.37B
| $563K | ﹤0.01% |
44,096
+14,047
| +47% | +$199K |
|
4571
US Commodity Index
USCI
$374M
| $563K | ﹤0.01% |
9,510
+67
| +0.7% | +$3.9K |
|
4572
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$60.9M
| $563K | ﹤0.01% |
10,415
+815
| +8% | +$45.2K |
|
|
SWZ
4573
Swiss Helvetia Fund
SWZ
$76.9M
| $563K | ﹤0.01% |
73,627
+5,486
| +8% | +$44.7K |
|
4574
Frontdoor
FTDR
$5.83B
| $562K | ﹤0.01% |
18,370
-32,231
| -64% | -$1.07M |
|
4575
La-Z-Boy
LZB
$1.64B
| $561K | ﹤0.01% |
18,158
-170,589
| -90% | -$5.25M |
|
Similar funds
UBS Group's Q3 2023 Portfolio in Review
As of Q3 2023, UBS Group held 10,416 positions worth $290B, down 2% from $296B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q3 2023 filing shows 1,615 new, 3,254 increased, 4,100 reduced and 999 closed positions. Its largest new stake was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M. The largest sale was NVIDIA, an estimated $538M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2023 buy was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M.
- UBS Group added most to Invesco QQQ Trust in Q3 2023, an estimated $440M increase.
- UBS Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $538M.
- UBS Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $245M.
- UBS Group's ten largest holdings make up 15% of its $290B portfolio in Q3 2023.
- UBS Group opened 1,615 new positions and closed 999 in Q3 2023.
- UBS Group's portfolio value fell 2% quarter-over-quarter to $290B.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.